JoVE Webinar: Regenerative Medicine Innovations

TL;DR

Webinar discusses canine ovarian stem cells for regenerative medicine.

Transcript

all right Welcome to our webinar today everyone my name is Ron Meers I'm the director of editorial here at Joe um so today we'll be having a webinar hosted by Amanda baraso so um her group published with us in 2018 um and you know she published a technique on mang M's stem cells so she's going to be updating us on the technique today um talking abo... Read More

Key Insights

• The webinar focused on the isolation, expansion, and differentiation of canine ovarian stem cells, highlighting their potential in regenerative medicine.
• Ovarian stem cells, often discarded as biological waste during spaying, can be transformed into a valuable tool for veterinary treatments.
• The presented method for isolating stem cells is cost-effective, avoiding the need for expensive cell sorting equipment.
• Innovations in the technique have reduced protocol time and increased cell yield, enhancing its feasibility for broader application.
• Stem cells derived from ovarian tissue demonstrate a wide differentiation capability, potentially aiding in various regenerative treatments.
• Clinical applications include successfully treating corneal ulcers in dogs, showcasing the practical utility of these stem cells.
• The technique has been adapted for different animal species, indicating its versatility and potential for wide-ranging veterinary use.
• Ovarian stem cells may possess greater pluripotency compared to other mesenchymal stem cells, suggesting broader therapeutic applications.

Questions & Answers

Q: What is the main focus of the webinar?

The webinar focuses on the isolation, expansion, and differentiation of canine ovarian stem cells, which are derived from ovaries typically discarded during spaying. These stem cells are being explored for their potential applications in regenerative medicine, particularly in veterinary treatments.

Q: How are ovarian stem cells obtained and processed?

Ovarian stem cells are obtained from ovaries post-spaying. The tissue is minced and treated with collagenase to break down collagen bonds, releasing the cells. These cells are then cultured in a T25 bottle, with a media change after three hours to select for rapidly adhering cells, resulting in a homogeneous stem cell population.

Q: What are the key innovations mentioned in the technique?

Key innovations include reducing the collagenase incubation time from three hours to one hour with magnetic agitation, which increases tissue digestion efficiency and cell yield. This adjustment shortens the protocol and enhances its feasibility for broader applications across different species.

Q: What are some clinical applications of these stem cells?

A notable clinical application is the treatment of corneal ulcers in dogs. In a case study, a dog with corneal ulcers was treated with an injection of ovarian stem cells, resulting in significant healing within 72 hours and complete recovery without surgical intervention, demonstrating the cells' regenerative potential.

Q: How do ovarian stem cells compare to other mesenchymal stem cells?

Ovarian stem cells may possess greater pluripotency than other mesenchymal stem cells, as indicated by their expression of pluripotent markers like Oct4. This suggests they could be more versatile in treating various medical conditions, offering broader therapeutic applications.

Q: Can this technique be applied to other species?

Yes, the technique has been successfully adapted for other species, including pigs and cows, with positive results. This adaptability indicates the method's potential for widespread use in veterinary regenerative medicine across different animal species.

Q: What challenges are associated with cell sorting in stem cell isolation?

Cell sorting can be expensive and potentially harmful to cells, resulting in lower yields of healthy cells. The webinar presents a cost-effective alternative that avoids the need for cell sorting equipment, making the process more accessible and efficient.

Q: What future research directions are suggested for ovarian stem cells?

Future research may focus on further exploring the pluripotency of ovarian stem cells and their potential applications in treating various conditions, such as neurological diseases. Ongoing studies could also investigate their use in other species and refine the isolation technique for improved efficiency and yield.

Summary & Key Takeaways

• The webinar discussed the innovative use of canine ovarian stem cells, typically considered waste, for regenerative medicine. The method is inexpensive and effective, allowing for the isolation of a homogeneous stem cell population without costly equipment. Key clinical applications include treating corneal ulcers in dogs, demonstrating significant healing potential.

• Significant advancements have been made in the technique, including reducing protocol time and increasing cell yield through magnetic agitation during collagenase incubation. The method's adaptability across various species, including pigs and cows, highlights its potential for widespread veterinary applications.

• Ovarian stem cells exhibit a broad differentiation capacity, potentially offering greater pluripotency than other mesenchymal stem cells. This characteristic makes them suitable for treating a variety of medical conditions, including neurological diseases, as ongoing research and clinical trials continue to explore their full potential.